Table 4.
Comparison of baseline characteristics of patients with and without refracture during follow-up.
| No refracture (N = 320) | Refracture (N = 52) | P-value | |
|---|---|---|---|
| Age (years) mean (SD), range | 79.8 (8.7) | 77.9 (10.0) | 0.1659 |
| Sex (female), n (%) | 239 (74.7) | 44 (84.6) | 0.12 |
| Type of fracture, n (%) | |||
| Pertrochanteric | 169 (52.8) | 22 (42.3) | 0.577 |
| Intracapsular | 126 (39.4) | 25 (48.1) | |
| Subtrochanteric | 20 (6.3) | 4 (7.7) | |
| Others | 5 (1.6) | 1 (1.9) | |
| Identification of patients, n (%) | |||
| Emergency registry | 184 (57.5) | 33 (63.5) | 0.383 |
| Admission | 115 (35.9) | 14 (26.9) | |
| Rheumatology osteoporosis clinic | 21 (6.6) | 5 (9.6) | |
| Previous treatment with bisphosphonates, n (%)a | 45 (14.2) | 8 (15.7) | 0.778 |
| Risk factors for fracture, n (%) | |||
| Previous fragility fracture | 63 (19.7) | 14 (26.9) | 0.232 |
| Parental hip fracture | 29 (9.1) | 6 (11.5) | 0.576 |
| Smoking | 29 (9.1) | 8 (15.4) | 0.158 |
| Corticosteroids | 35 (11.0) | 5 (9.6) | 0.77 |
| Rheumatoid arthritis | 9 (2.8) | 1 (2.0) | 0.723 |
| Secondary osteoporosis | 49 (15.3) | 11 (21.2) | 0.288 |
| Alcohol | 14 (4.4) | 3 (5.8) | 0.655 |
| Densitometry results, n (%)a | |||
| Normal | 10 (5.8) | 2 (5.9) | 0.879 |
| Osteopenia | 69 (39.9) | 12 (35.3) | |
| Osteoporosis | 94 (54.3) | 20 (58.8) | |
| T score lumbar spine, mean (SD) | − 1.8 (1.6) | − 2.4 (1.6) | 0.073 |
| T score femoral neck, mean (SD) | − 2.4 (1.1) | − 2.8 (1.0) | 0.088 |
| FRAX® | |||
| FRAX® major, mean (SD) | 18.2 (10.1) | 19.8 (10.9) | 0.304 |
| FRAX® hip, mean (SD) | 9.6 (8.1) | 10.9 (9.5) | 0.284 |
| Referral after baseline visit, n (%)a | |||
| Rheumatology osteoporosis clinic | 50 (15.6) | 7 (13.5) | 0.688 |
| Primary care | 270 (84.4) | 45 (86.5) | |
aPrevious treatment recorded in 369 patients. Densitometry values were recorded in 207 patients.